Tag: BSX

  • Early Morning Vibes: Don’t Miss On These 4 Growth Stocks

    Early Morning Vibes: Don’t Miss On These 4 Growth Stocks

    On February 2, the American stock indexes finished trading in the green zone. The S&P 500 climbed 1.39% to 3826 points, the Dow Jones rose 1.57% and the NASDAQ rose 1.56%. The news background did not contain new drivers of movement, but risk appetite was increased due to the decrease in fears of an overbought market. All 11 sectors closed in positive territory. The finance sector-led growth with 2.46%, driven by a rebound in Treasury yields.

    Company news

    Uber (UBER: + 7%) today announced it has acquired the liquor delivery service Drizly for $1.1 billion in company stock and cash.

    Pfizer’s revenue (PFE: -2.3%) beat expectations, although EPS was weaker than consensus. The 2021 revenue forecast assumes strong sales of coronavirus vaccines.

    Results of oil giant BP (BP: -6.6%) were worse than expected in various segments, dividends were reduced by 50%.

    Today, world stock exchanges are showing mostly positive dynamics. The fight against the coronavirus remains in focus and the news on this front is mostly positive. The attention of international investors was attracted by the results of tests of the Russian vaccine Sputnik V, which revealed its high efficiency. In addition, the University of Oxford has published encouraging research results that indicate that the AstraZeneca vaccine not only prevents coronavirus disease but also reduces its spread by two-thirds. This is the first study to document that vaccine proliferation will lead to a rapid decline in disease incidence. In the United States, more than 7% of the population has already received the first dose of the vaccine, and the daily incidence of COVID-19 has rolled back to November levels.

    Quarterly results were published by 43% of companies in the S&P 500. At present, aggregate net income for the fourth quarter is expected to show growth YoY, while in October it was forecast to decline by 13% YoY. This signals that companies’ financials are showing an unexpectedly fast recovery. However, the optimistic expectations have already been partially taken into account in the quotes, as evidenced by the increase in the S&P 500 by 17% over the past three months.

    Sentiment Index

    The Freedom Finance Sentiment Index remains at 68 out of 100. The indicator reflects market participants’ hope for a global economic recovery in 2021. Concerns about the negative impact of the coronavirus pandemic are slowly diminishing with the prospect of mass vaccinations.

    Technical picture

    Technically, the S&P 500 is still bullish in the medium term. The broader market index has continued to rebound from the 50-day moving average, but the strength of this impulse is fading. In the short term, consolidation is likely, as the RSI indicator is in the neutral zone and indicates the equality of forces between the bulls and bears, while the MACD indicator remains in negative territory.

    Today Top Movers

    Sundial Growers Inc (SNDL) stock moved up 8.65 percent to $1.13 in the pre-market ‎trading. The firm recently revealed the closing of its US$100 million registered offering.‎‎
    ‎ ‎‎
    ‎AMC Entertainment Holdings Inc (AMC) stock ascended 8.44% at $8.48 in the pre-market trading today.‎‎
    ‎ ‎‎
    Naked Brand Group Ltd (NAKD) an apparel manufacturing company, soared about 12.07% ‎at $1.02 in pre-market ‎trading Wednesday following the declaration of closing $50 million registered direct offering priced at-the-market.
    ‎ ‎‎
    ‎Cps Technologies (CPSH) share price jumped 21.75% to $8.45 during the early morning ‎trading session on ‎Wednesday.‎‎ The company recently declared receipt of a purchase order for HybridTech Armor© Panels to be installed as the strike face of advanced ballistic shields to support U.S. Navy CVN class ships.

    Top Upgrades & Downgrades

    Oppenheimer turned bullish on NXP Semiconductors N.V. (NXPI), upgrading the stock to “Outperform” and assigning a $210.0 price target, representing a potential downside of 18.5% from Tuesday’s close. 

    Nucor Corporation (NUE) has won the favor of Credit Suisse’s equity research team. The firm upgraded the shares from Neutral to Outperform and moved their price target to $63.0, suggesting a 24.85% additional upside for the stock. 

    Steel Dynamics Inc. (STLD) received an upgrade from analysts at Credit Suisse, who also set their one-year price target on the stock to $52.0. They changed their rating on STLD to Outperform from Neutral in a recently issued research note. 

    Earlier Tuesday Credit Suisse reduced its rating on SBA Communications Corporation (SBAC) stock to Neutral from Outperform and assigned the price target to $291.0. With shares trading at around $281.90, the Wall Street firm thinks SBA Communications Corporation’s stock could add than 3.23%. 

    JPMorgan analysts reduced their investment ratings, saying in research reports covered by the media that it’s rating for Centennial Resource Development Inc. (CDEV) has been changed to Underweight from Neutral. 

    Analysts at JPMorgan ‎downgraded Cabot Oil & Gas Corporation (COG)’s stock to Neutral from Overweight Wednesday.

    Latest Insider Activity

    Moderna Inc. (MRNA) Andres Juan announced the sale of shares taking place on Feb 01 at $172.99 for some 5,000 shares. The total came to more than $0.86 million. 

    Visa Inc. (V) CHAIRMAN & CEO KELLY ALFRED F JR sold on Jan 29 a total of 163,112 shares at $197.73 on average. The insider’s sale generated proceeds of almost $1.78 million. 

    Surgalign Holdings Inc. (SRGA) Director STOLPER MARK declared the purchase of shares taking place on Feb 01 at $1.50 for some 16,667 shares. The transaction amount was around $25001.0. 

    Outlook Therapeutics Inc. (OTLK) Director Sukhtian Ghiath M. bought on Feb 02 a total of 10,820,630 shares at $1.00 on average. The purchase cost the insider an estimated $8.36 million.

    Important Earnings

    Top US earnings releases scheduled for today include Boston Scientific Corporation (NYSE: BSX). It will announce its Dec 2020 financial results. The company is expected to report earnings of $0.31 per share from revenues of $2.83B in the three-month period. 

    Analysts expect AbbVie Inc. (NYSE: ABBV) to report a net income (adjusted) of $2.85 per share when the bank releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $13.7B. 

    eBay Inc. (EBAY), due to announce earnings after the market closes today, is expected to report earnings of $0.83 per share from revenues of $2.7B recently concluded three-month period.

  • Top 15 Best Performing Medical Device Manufacture Companies Of 2020

    Top 15 Best Performing Medical Device Manufacture Companies Of 2020

    New medical innovations are emerging day by day and are playing a major role in the health care sector. Much of the credit for these new technological innovations go to the medical devices industry. Technological advancement is continuously changing the medical devices industry. The medical devices that provide and analyze data of patients within minutes are aiding the healthcare organizations to improve patients outcomes, lower costs, and enhance efficiency.

    2020 is the year of challenges and opportunities for many industries including the medical devices industry. The medical device industry is growing with fast speed and it doesn’t seem like it is going to be slowing down anytime soon. The growth in the medical devices industry has occurred because of increasing severe disease with the increasing population. These new diseases need new treatments that can reduce the symptoms in patients. The medical devices industry is important to patients for many reasons. Medical devices companies engaged in the innovations of new technologies that are helpful for patients with chronic diseases.

    Here are the top 15 leading players in the medical devices industry you should be holding right now:

    SmileDirectClub Inc. (NASDAQ: SDC)

    SmileDirectClub Inc. (NASDAQ: SDC) last closed at $11.27, in a 52-week range of $3.64 to $21.10. Analysts have a consensus price target of $10.08. SmileDirectClub Inc. (SDC) has partnered with Meredith Corporation (MDP) to introduce Telehealth Explained. Telehealth Explained is the new platform aimed to educate consumers about the many benefits of telehealth for physical, mental, and dental health.  SmileDirectClub Inc.’s market cap has remained high, hitting $4.66 billion at the time of writing.

    CHF Solutions Inc. (CHFS)

    CHF Solutions Inc. (CHFS) stock soar by 5.85% to $0.32. CHF Solutions Inc. (CHFS) has earlier disclosed that it has received 180-extension to meet the Nasdaq minimum bid price requirement. The company has now the time since February 24, 2021, to meet all the requirements.  CHFS has earlier hosted the interactive, physician-led webinar to discuss “Precision Medicine for the Treatment of Fluid Overload in Patients with Acute Heart Failure.” CHF Solutions has a 52-weeks low and high range of $0.28 and a low range of $2.92.

    Abbott Laboratories (NYSE: ABT)

    Abbott Laboratories (NYSE: ABT) stock soar by 2.89% to $105.81. The most recent rating by Goldman, on June 01, 2020, is at a Sell. Abbott Laboratories (ABT) has earlier disclosed that it has initiated the LIFE-BTK clinical trial to evaluate the safety and effectiveness of the company’s new Esprit™ BTK Everolimus-Eluting Resorbable Scaffold System.  ABT has a 52-weeks low and high range of $61.61 and $114.19, respectively. It has a market cap of $189.80 billion at the time of writing.

    Avinger Inc. (NASDAQ: AVGR)

    Avinger Inc. (NASDAQ: AVGR) Shares headed rising, higher as much as 3.70%. The most recent rating by Ladenburg Thalmann, on March 09, 2018, is at a Buy. Avinger Inc. (AVGR) has earlier disclosed that the underwriter of its earlier revealed underwritten public offering has practiced, in full, their option to purchase an additional 1,000,000 shares of the Company’s common stock at a price of $0.47 per share. Avinger Inc.’s market capitalization has remained high, hitting $36.67 million at the time of writing.

    InspireMD Inc. (AMEX: NSPR)

    InspireMD Inc. (AMEX: NSPR) fall -7.23% after losing more than -$0.02 on Wednesday. InspireMD Inc. has disclosed that it has received the FDA approval to proceed with a pivotal study of the CGuard Carotid Stent System, CARENET-III, for prevention of stroke in patients in the United States.  The FDA approval of Investigational Device Exemption (IDE) has been proved to be useful for the company as it is now able to conduct the trial to check the potential of CGuard EPS against carotid artery disease.

    BIOLASE Inc. (NASDAQ: BIOL)

    BIOLASE Inc. (NASDAQ: BIOL) last closed at $0.30, in a 52-week range of $0.21 to $1.16. BIOLASE Inc. (BIOL) has disclosed that Todd Norbe, President and CEO, and John Beaver, COO, and CFO, will be providing an overview of the Company, as well as recent progress and achievements at the Colliers & Co.  Institutional Investor Conference on Thursday, September 10, 2020. BIOLASE Inc. has a market capitalization of $26.66 million at the time of writing.

    Stryker Corporation (NYSE: SYK)

    Stryker Corporation (NYSE: SYK) stock soar by 2.66% to $205.41. The most recent rating by Barclays, on April 13, 2020, is at an Underweight. Stryker Corporation (SYK) has earlier revealed that it will take part in the Morgan Stanley 18th Annual Virtual Global Healthcare Conference on Tuesday, September 15, 2020. This company’s market capitalization has remained high, hitting $77.31 billion at the time of writing.

    Livongo Health Inc. (NASDAQ: LVGO)

    Livongo Health Inc. (NASDAQ: LVGO) last closed at $128.03, in a 52-week range of $15.12 to $150.00. Analysts have a consensus price target of $130.41. Livongo Health Inc. (LVGO) disclosed that executives of Livongo Health and the executives from Teladoc Health will be participating in the following upcoming investor conferences. It had a trading volume of 1.72 million as compared to the average volume of 4.89 million.

    Boston Scientific Corporation (NYSE: BSX)

    Boston Scientific Corporation (NYSE: BSX) shares headed rising, higher as much as 1.49% after Boston Scientific Launches Vercise Genus™ DBS System In Europe. The most recent rating by SVB Leerink, on April 22, 2020, is at an Mkt perform. Boston Scientific Corporation (BSX) has a 52-weeks low and high range of $24.10 and $46.62, respectively. It has a market cap of $59.43 billion at the time of writing.

    Medtronic plc (NYSE: MDT)

    Medtronic plc (NYSE: MDT) rose 1.99% after gaining more than $2.08 on Wednesday. Medtronic Receives Breakthrough Device Designation from FDA, Begins Early Feasibility Study for Investigational Intrepid™ Transcatheter Valve System for the Treatment of Tricuspid Valve Regurgitation. Medtronic plc (MDT) has traded up 47.87% from its 52-weeks low and traded down -12.68% from its 52-weeks high.

    Ra Medical Systems Inc. (RMED)

    Ra Medical Systems Inc. (RMED) last closed at $0.25, in a 52-week range of $0.26 to $2.69. Ra Medical Systems to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 16. Ra Medical Systems Inc. (RMED) has traded down -2.46% from its 52-weeks low and traded down 90.57% from its 52-weeks high.

    Hancock Jaffe Laboratories Inc. (NASDAQ: HJLI)

    Hancock Jaffe Laboratories Inc. (NASDAQ: HJLI) shares were trading up 12.80% at $0.41 at the time of writing on Wednesday. Hancock Jaffe Laboratories Inc. (NASDAQ: HJLI) share price went from a low point around $0.21 to briefly over $1.03 in the past 52 weeks, though shares have since pulled back to $0.41. HJLI market cap has remained high, hitting $16.12M at the time of writing.

    Nano-X Imaging Ltd. (NASDAQ: NNOX)

    Nano-X Imaging Ltd. (NASDAQ: NNOX) shares headed rising, higher as much as 7.76% after Nanox Signs Agreement With SPI Medical for the Deployment of 630 Nanox. Its stock has fluctuated between the 52-weeks low of $20.25 and a 52-weeks high range of $43.48. NNOX has moved up 117.33% and 1.24% from its 52-weeks low and high, respectively. Its market capitalization has remained high, hitting $2.08 billion.

    Edwards Lifesciences Corporation (NYSE: EW)

    Edwards Lifesciences Corporation (NYSE: EW) rose 3.26% after gaining more than $2.68 on Wednesday. Edwards Lifesciences Corporation (EW) stock has fluctuated between the 52-weeks low of $51.51 and a 52-weeks high range of $87.79. EW has moved up 64.72% from its 52-weeks low and moved down -3.36% from its 52-weeks high, respectively. Its market capitalization has remained high, hitting $54.00 billion.

    Wright Medical Group N.V. (NASDAQ: WMGI)

    Wright Medical Group N.V. (NASDAQ: WMGI) stock drop by -0.26% to $30.30. The most recent rating by Jefferies, on December 24, 2019, is at a Hold. Wright Medical Group N.V. (WMGI) has a 52-weeks low and high range of $19.04 and $30.66, respectively. It has a market capitalization of $2.92 billion.